Micheál Martin
Question:223. Deputy Micheál Martin asked the Minister for Health if he has sought any reports on trials in the usage of medicinal cannabis on children in Colorado; and if he will make a statement on the matter. [2405/17]
View answerThursday, 19 January 2017
Questions (223, 224)
Micheál Martin
Question:224. Deputy Micheál Martin asked the Minister for Health the European practices that are being examined or followed in relation to the provision of medicinal cannabis to children with epilepsy; and if he will make a statement on the matter. [2406/17]
View answerWritten answers
I propose to take Questions Nos. 223 and 224 together.
Cannabis is strictly controlled under the Misuse of Drugs Acts 1977 - 2016. However, I am conscious that some patients believe that cannabis should be available as a treatment for a range of medical conditions and I have initiated a review of policy in this area.
On 3 November 2016 I asked the Health Products Regulatory Authority (HPRA) for expert advice. The HPRA’s statutory role is to protect and enhance human health by regulating medicines and other health products and it has the necessary clinical and scientific expertise to advise on this issue. In particular, I have requested that the HPRA provide advice on recent developments in the use of cannabis for medical purposes including an overview of products that have been authorised in other countries and an overview of the wider on-going and emerging clinical research in new indications and evidence of efficacy. I have also requested information on the different regulatory regimes in place in countries which allow cannabis to be used for medicinal purposes.
I expect to receive an initial report from the HPRA by the end of January. I will then be in a position to consider future policy and progress any legislative changes that may be appropriate.